Detalles de la búsqueda
1.
Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report.
Kidney Med
; 5(8): 100682, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415622
2.
The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications.
J Mol Med (Berl)
; 101(10): 1229-1236, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584739
3.
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.
Cancer Med
; 12(18): 18872-18881, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37724607
4.
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre study.
Eur J Cancer
; 142: 83-91, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33242835
5.
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.
J Clin Oncol
; 37(4): 278-285, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30550363
6.
Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.
Cancer Discov
; 8(12): 1529-1539, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30257958
7.
Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed EGFR Mutant Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 12017.
Artículo
en Inglés
| MEDLINE | ID: mdl-31032471
Resultados
1 -
7
de 7
1
Próxima >
>>